On Target, On Track: Navigating LDL-C Management in Appropriate Patients With Primary Hyperlipidemia 在目标上,在轨道上:在适当的原发性高脂血症患者中引导LDL-C管理 Maisha Bryant East Hanover, NJ On Target, On Track: Navigating LDL-C ...
On Target, On Track: Navigating LDL-C Management in Appropriate Patients With Primary Hyperlipidemia 在目标上,在轨道上:在适当的原发性高脂血症患者中引导LDL-C管理 Maisha Bryant East Hanover, NJ On Target, On Track: Navigating LDL-C Management in Appropriate Patients With Primary Hyperlipidemia 在目...
前言2024年4月7日,恒瑞医药一类创新药前蛋白转换酶枯草溶菌素9(PCSK9)单克隆抗体瑞卡西单抗第三度登上国际学术舞台——第73届美国心脏病学会科学年会(ACC.24)。ACC年会是心血管领域最重要的国际会议之一,至少有14000余名从事心血管疾病研...
On Target, On Track: Navigating LDL-C Management in Appropriate Patients With Primary Hyperlipidemia 在目标上,在轨道上:在适当的原发性高脂血症患者中引导LDL-C管理 Maisha Bryant East Hanover, NJ On Target, On Track: Navigating LDL-C ...
For that reason, AMPK protein may be considered to be a pharmacological target for the management of hyperlipidemia or atherosclerosis. Characterized by its clarity, sanitary quality, plentiful nutrients, particularly rich in ionic magnesium (Mg2+), calcium (Ca2+), and potassium (K+), deep sea ...